Table 4.
Summary of immunohistochemical marker expression status in primary epididymal adenocarcinoma.
| Marker | Primary epididymal adenocarcinoma | |
|---|---|---|
| Positive/total cases | Negative/total cases | |
| CEA | 2/5 | 3/5 |
| PSA | 0/5 | 5/5 |
| CK7 | 2/4 | 2/4 |
| EMA | 4/4 | 0/4 |
| AFP | 0/3 | 3/3 |
| Calretinin | 0/3 | 3/3 |
| CD10 | 3/3 | 0/3 |
| Vimentin | 1/3 | 2/3 |
| CA19-9 | 1/2 | 1/2 |
| CAIX | 2/2 | 0/2 |
| CD30 | 0/2 | 2/2 |
| CDX2 | 0/2 | 2/2 |
| CK | 2/2 | 0/2 |
| CK20 | 1/2 | 1/2 |
| C-KIT | 0/2 | 2/2 |
| HBME1 | 1/2 | 1/2 |
| Inhibin | 0/2 | 2/2 |
| Leu-M1 | 0/2 | 2/2 |
| PAP | 0/2 | 2/2 |
| PAS | 2/2 | 0/2 |
| PLAP | 0/2 | 2/2 |
| S100 | 0/2 | 2/2 |
| TTF-1 | 0/2 | 2/2 |
| WT1 | 0/2 | 2/2 |
| AMACR | 0/1 | 1/1 |
| B72.3 | 0/1 | 1/1 |
| Ber-EP4 | 0/1 | 1/1 |
| CA125 | 0/1 | 1/1 |
| CAM5.2 | 1/1 | 0/1 |
| CK5 | 0/1 | 1/1 |
| CK AE1/AE3 | 1/1 | 0/1 |
| Glypican | 0/1 | 1/1 |
| GST-α | 0/1 | 1/1 |
| HCG | 0/1 | 1/1 |
| LCA | 0/1 | 1/1 |
| Melan-A | 0/1 | 1/1 |
| Mesothelin | 1/1 | 0/1 |
| P53 | 1/1 | 0/1 |
| PAX2 | 1/1 | 0/1 |
| PROSAP | 0/1 | 1/1 |
| RCC | 0/1 | 1/1 |
| SALL4 | 0/1 | 1/1 |
| Villin | 1/1 | 0/1 |
| Vinculin | 1/1 | 0/1 |